Literature DB >> 16226233

Myostatin, the cardiac chalone of insulin-like growth factor-1.

Vinciane Gaussin, Christophe Depre.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16226233     DOI: 10.1016/j.cardiores.2005.09.007

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


× No keyword cloud information.
  18 in total

1.  POTENTIAL NON-GROWTH USES OF rhIGF-I.

Authors:  Roy J Kim; Adda Grimberg
Journal:  Growth Genet Horm       Date:  2007-03

2.  Myostatin activation in patients with advanced heart failure and after mechanical unloading.

Authors:  Isaac George; Lawrence T Bish; Gayathri Kamalakkannan; Christopher M Petrilli; Mehmet C Oz; Yoshifumi Naka; H Lee Sweeney; Simon Maybaum
Journal:  Eur J Heart Fail       Date:  2010-03-27       Impact factor: 15.534

3.  What can genetic studies of left ventricular mass tell us?

Authors:  Christopher Newton-Cheh
Journal:  Circ Cardiovasc Genet       Date:  2011-12

4.  Myostatin is upregulated following stress in an Erk-dependent manner and negatively regulates cardiomyocyte growth in culture and in a mouse model.

Authors:  Lawrence T Bish; Kevin J Morine; Meg M Sleeper; H Lee Sweeney
Journal:  PLoS One       Date:  2010-04-19       Impact factor: 3.240

Review 5.  Clinical, agricultural, and evolutionary biology of myostatin: a comparative review.

Authors:  Buel D Rodgers; Dilip K Garikipati
Journal:  Endocr Rev       Date:  2008-06-30       Impact factor: 19.871

6.  Myostatin represses physiological hypertrophy of the heart and excitation-contraction coupling.

Authors:  Buel D Rodgers; Jillian P Interlichia; Dilip K Garikipati; Ranganath Mamidi; Murali Chandra; O Lynne Nelson; Charles E Murry; Luis F Santana
Journal:  J Physiol       Date:  2009-09-07       Impact factor: 5.182

7.  Four genetic loci influencing electrocardiographic indices of left ventricular hypertrophy.

Authors:  Sonia Shah; Christopher P Nelson; Tom R Gaunt; Pim van der Harst; Timothy Barnes; Peter S Braund; Debbie A Lawlor; Juan-Pablo Casas; Sandosh Padmanabhan; Fotios Drenos; Mika Kivimaki; Philippa J Talmud; Steve E Humphries; John Whittaker; Richard W Morris; Peter H Whincup; Anna Dominiczak; Patricia B Munroe; Toby Johnson; Alison H Goodall; Francois Cambien; Patrick Diemert; Christian Hengstenberg; Willem H Ouwehand; Janine F Felix; Nicole L Glazer; Maciej Tomaszewski; Paul R Burton; Martin D Tobin; Dirk J van Veldhuisen; Rudolf A de Boer; Gerjan Navis; Wiek H van Gilst; Bongani M Mayosi; John R Thompson; Meena Kumari; Peter W MacFarlane; Ian N M Day; Aroon D Hingorani; Nilesh J Samani
Journal:  Circ Cardiovasc Genet       Date:  2011-09-30

8.  Myostatin is elevated in congenital heart disease and after mechanical unloading.

Authors:  Lawrence T Bish; Isaac George; Simon Maybaum; Jonathan Yang; Jonathan M Chen; H Lee Sweeney
Journal:  PLoS One       Date:  2011-09-13       Impact factor: 3.240

9.  Age Trends in Growth and Differentiation Factor-11 and Myostatin Levels in Healthy Men, and Differential Response to Testosterone, Measured Using Liquid Chromatography-Tandem Mass Spectrometry.

Authors:  Liming Peng; Thiago Gagliano-Jucá; Karol M Pencina; Srinivasan Krishnan; Zhuoying Li; Russell P Tracy; Ravi Jasuja; Shalender Bhasin
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2022-04-01       Impact factor: 6.591

10.  Myostatin and insulin-like growth factor I: potential therapeutic biomarkers for pompe disease.

Authors:  Yin-Hsiu Chien; Der-Sheng Han; Wuh-Liang Hwu; Beth L Thurberg; Wei-Shiung Yang
Journal:  PLoS One       Date:  2013-08-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.